Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us 
About
AIChE Annual MeetingAIChE Annual Meeting
Not Confirmed
Not Confirmed
02-06 November, 2025
Not Confirmed
Not Confirmed
03-06 November, 2025
Not Confirmed
Not Confirmed
03-05 November, 2025
List your booth number for exhibitions, ask us 
CONTACT DETAILS





Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
AIChE Annual MeetingAIChE Annual Meeting
Industry Trade Show
Not Confirmed
02-06 November, 2025
Industry Trade Show
Not Confirmed
03-06 November, 2025
Industry Trade Show
Not Confirmed
03-05 November, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-re-expanding-our-cdmo-capabilities-to-meet-the-next-wave-of-complex-therapies-starting-with-oncology
VLOG #PharmaReel
[Sponsored by another company] 
					DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-chemexpress-invest-in-adc-facilities-cohance-to-set-up-oligonucleotide-facility-in-india

22 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/22/3153626/0/en/CROSSJECT-Secures-Additional-BARDA-Funding-for-the-Progressive-Developmental-and-FDA-Authorization-of-the-ZEPIZURE-ZENEO-Midazolam.html

04 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/04/3126727/0/en/CROSSJECT-remains-engaged-during-the-summer-break.html

24 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/24/3104583/0/en/CROSSJECT-announces-a-successful-capital-increase-of-5-7-million-following-full-exercise-of-the-extension-clause.html

11 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/11/3097270/0/en/CROSSJECT-advances-on-the-development-of-ZEPIZURE-Junior-its-solution-for-epilepsy-crises-in-children.html

04 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/04/3093932/0/en/Launch-of-a-capital-increase-with-preferential-subscription-rights-for-nearly-5-million-euros.html

03 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/03/3092432/0/en/Maxim-Group-initiates-the-coverage-of-the-CROSSJECT-share-with-a-BUY-recommendation-and-a-target-price-of-4-00.html
ABOUT THIS PAGE
